Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00030394 · COMPLETED

Trial details

NCT number: NCT00030394
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia

Start date: 2002-09-01
Primary completion: 2007-10-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.